Firm Uses Artificial Intelligence In Drug Development

03:59

March 17, 2015

It’s called BPM 31510 and it is one of many cancer drugs being developed around the country. But it’s also different.

BPM 31510 may be the first drug candidate that was developed by artificial intelligence, instead of scientists running experiments based on a hypothesis.

From the Here & Now Contributors Network, WBUR's Curt Nickisch reports.

WBUR: Framingham Startup Uses Artificial Intelligence To Find Cancer Drugs

Reporter

Curt Nickisch, business and technology reporter for WBUR. He tweets @CurtNickisch.

This segment aired on March 17, 2015.